Skip to main content
logo
Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India flag India · Delayed Price · Currency is INR
424.80
+4.30 (1.02%)
At close: Jan 23, 2026

NSE:AKUMS Revenue

Akums Drugs and Pharmaceuticals had revenue of 10.18B INR in the quarter ending September 30, 2025, a decrease of -1.51%. This brings the company's revenue in the last twelve months to 41.10B, up 0.68% year-over-year. In the fiscal year ending March 31, 2025, Akums Drugs and Pharmaceuticals had annual revenue of 41.21B, down -1.45%.

Revenue (ttm)
41.10B
Revenue Growth
+0.68%
P/S Ratio
1.58
Revenue / Employee
5.45M
Employees
7,536
Market Cap
65.04B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202541.21B-605.31M-1.45%
Mar 31, 202441.82B5.24B14.34%
Mar 31, 202336.57B-180.32M-0.49%
Mar 31, 202236.75B9.49B34.81%
Mar 31, 202127.26B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Alembic Pharmaceuticals70.83B
Strides Pharma Science46.85B
NATCO Pharma43.90B
Alivus Life Sciences24.81B
Aarti Pharmalabs19.06B
Innova Captab13.63B
Cohance Lifesciences12.11B
Solara Active Pharma Sciences12.06B
Revenue Rankings

Akums Drugs and Pharmaceuticals News

More News